查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451577

2024-2032 年按測試、產品、最終用戶和地區分類的臨床診斷市場報告

Clinical Diagnostics Market Report by Test, Product, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2023年全球臨床診斷市場規模達到816億美元。展望未來， IMARC Group預計到2032年市場規模將達到1,438億美元，2024-2032年複合年成長率（CAGR）為6.4%。自體免疫疾病數量的不斷增加、醫療旅遊的上升趨勢（特別是在擁有先進醫療保健系統的國家）以及對個人化醫療和診斷的日益成長的傾向是推動市場的一些主要因素。

臨床診斷是指專注於檢測和識別疾病和醫療狀況的醫學分支。它們使醫療保健專業人員能夠透過各種測試、程序和評估準確診斷各種疾病。它們提供可靠且及時的資訊，有助於醫療決策。它們還為臨床醫生提供對於評估患者健康、規劃治療方案以及採用一系列複雜方法進行預後評估至關重要的資料。它們透過支持準確的早期診斷在醫療保健中發揮重要作用，從而促進預防性護理並監測治療的有效性。

狼瘡和類風濕性關節炎等自體免疫疾病的數量不斷增加，推動了對專門臨床診斷的需求，以便在世界範圍內及早發現這些疾病並對其進行有效管理。此外，醫療旅遊的上升趨勢，特別是在擁有先進醫療保健系統的國家，正在刺激對廣泛臨床診斷測試的需求。此外，由於慢性病和傳染病的盛行率激增，以及人口老化加劇（更容易出現這些疾病），人們越來越傾向於個人化醫療和診斷，這對市場產生了積極影響。除此之外，專業診斷中心數量的增加確保更容易獲得檢測，這有利於市場的成長。此外，人們越來越喜歡床邊檢測（POC​​T），醫療保健提供者可以在床邊快速輕鬆地診斷和監測患者，這為市場創造了積極的前景。

臨床診斷市場趨勢/促進因素：

生活方式疾病增加

在全球範圍內，肥胖、高血壓和糖尿病等與生活方式相關的疾病的盛行率呈上升趨勢。現今普遍存在的久坐生活方式和不良飲食習慣是導致這些疾病的主要原因。臨床診斷在早期發現、促進預防措施和客製化治療計劃方面發揮著至關重要的作用。及時診斷通常可以挽救生命，並可以減輕醫療保健系統的整體負擔。因此，生活方式疾病的增加提高了對先進臨床診斷技術的需求，以有效管理和控制這些疾病。

醫療保健意識的提高

公眾越來越意識到醫療保健和預防措施的重要性，部分原因是透過網路和公共衛生運動獲取資訊的機會增加。這種意識的提高導致越來越多的人尋求定期檢查和診斷測試作為預防性醫療保健的一部分。這種主動的健康管理極大地推動了對臨床診斷的需求，因為個人尋求了解他們的健康指標並儘早發現潛在的問題。

不斷成長的政府措施和政策

世界各國政府都在大力投資醫療基礎設施，並推行鼓勵定期醫療檢查的政策。醫療保健補貼、針對早期疾病檢測的公共衛生運動以及增加醫學研究資金等措施對臨床診斷的需求產生直接影響。這些計劃使人們更容易獲得和負擔得起診斷服務，從而提高了利用率。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球臨床診斷市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：通過測試

  • 脂質面板
    • 市場走向
    • 市場預測
  • 肝臟面板
    • 市場走向
    • 市場預測
  • 腎臟檢查
    • 市場走向
    • 市場預測
  • 全血球計數
    • 市場走向
    • 市場預測
  • 電解質測試
    • 市場走向
    • 市場預測
  • 傳染病檢測
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依產品

  • 儀器
    • 市場走向
    • 市場預測
  • 試劑
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依最終用戶

  • 醫院實驗室
    • 市場走向
    • 市場預測
  • 診斷實驗室
    • 市場走向
    • 市場預測
  • 即時檢測
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Siemens AG
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A5998

The global clinical diagnostics market size reached US$ 81.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 143.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6.4% during 2024-2032. The increasing number of autoimmune disorders, rising trend of medical tourism, particularly in countries with advanced healthcare systems, and the growing inclination towards personalized medicine and diagnostics are some of the major factors propelling the market.

Clinical diagnostics refer to a branch of medicine that focuses on detecting and identifying diseases and medical conditions. They allow healthcare professionals to accurately diagnose a wide range of illnesses through various tests, procedures, and evaluations. They provide reliable and timely information that aids in medical decision making. They also offer clinicians data that is vital for assessing patient health, planning treatment protocols, and making prognostic evaluations by employing a range of sophisticated methodologies. They play an essential role in healthcare by supporting accurate and early diagnoses, which facilitates preventive care and monitors the effectiveness of treatments.

The increasing number of autoimmune disorders like lupus and rheumatoid arthritis are driving the need for specialized clinical diagnostics to detect these conditions early and manage them effectively around the world. Moreover, the rising trend of medical tourism, particularly in countries with advanced healthcare systems, is catalyzing the demand for a wide range of clinical diagnostic tests. In addition, the growing inclination towards personalized medicine and diagnostics on account of the surging prevalence of chronic and infectious diseases and the increasing aging population, which is more prone to develop these medical conditions, is influencing the market positively. Apart from this, the rising number of specialized diagnostic centers ensure easier access to testing, which is favoring the growth of the market. Furthermore, the growing preference for point of care testing (POCT) that allows healthcare providers to diagnose and monitor patients at the point of care quickly and easily is creating a positive outlook for the market.

Clinical Diagnostics Market Trends/Drivers:

Increase in lifestyle diseases

The prevalence of lifestyle-related diseases like obesity, hypertension, and diabetes is on the upswing, globally. The sedentary lifestyles and poor dietary habits prevalent today contribute significantly to these conditions. Clinical diagnostics play a crucial role in early detection, facilitating preventive measures and tailored treatment plans. Timely diagnosis can often be lifesaving and can reduce the overall burden on healthcare systems. The rise in lifestyle diseases thereby elevates the need for advanced clinical diagnostics to manage and contain these conditions effectively.

Rise in healthcare awareness

The public is becoming more aware about the importance of healthcare and preventative measures, partly due to increased accessibility to information via the internet and public health campaigns. This increased awareness is leading to a higher rate of people seeking regular check-ups and diagnostic tests as part of preventative healthcare. Such proactive health management significantly drives the demand for clinical diagnostics, as individuals seek to understand their health metrics and catch potential issues early.

Growing government initiatives and policies

Governments worldwide are investing heavily in healthcare infrastructure and promoting policies that encourage regular medical screenings. Initiatives, such as subsidized healthcare, public health campaigns targeting early disease detection, and increased funding for medical research have a direct impact on the demand for clinical diagnostics. These programs make diagnostic services more accessible and affordable for the population, thereby driving up utilization rates.

Clinical Diagnostics Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global clinical diagnostics market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on test, product, and end user.

Breakup by Test:

Lipid Panel

Liver Panel

Renal Panel

Complete Blood Count

Electrolyte Testing

Infectious Disease Testing

Others

Lipid panel dominates the market

The report has provided a detailed breakup and analysis of the market based on the test. This includes lipid panel, liver panel, renal panel, complete blood count, electrolyte testing, infectious disease testing, and others. According to the report, lipid panel represented the largest segment. A lipid panel is a blood test that measures different types of fats and cholesterol levels in the blood, notably low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides. The test provides valuable information about the risk for heart disease of an individual and helps guide decisions about what treatment can be best if there is borderline or high risk.

A liver panel is a group of blood tests that evaluate the function of the liver and check for signs of liver damage or inflammation. The panel can include tests like alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin, among others. These results can aid in diagnosing liver diseases such as hepatitis or cirrhosis, and can also monitor the effects of certain medications on the liver.

The renal panel, also commonly known as a kidney panel, consists of various tests aimed at assessing kidney function. It often includes measurements of elements such as creatinine, blood urea nitrogen (BUN), and electrolytes like sodium, potassium, and chloride. The test is critical for diagnosing kidney diseases and for monitoring individuals who are at risk for kidney complications due to conditions like diabetes or high blood pressure.

Breakup by Product:

Instruments

Reagents

Others

Instruments holds the largest share in the market

A detailed breakup and analysis of the market based on the product has also been provided in the report. This includes instruments, reagents, and others. According to the report, instruments accounted for the largest market share. Instruments in clinical diagnostics refer to the specialized machinery and devices used to carry out various tests. These range from simple equipment like centrifuges, which separate different components of blood, to more complex machines like polymerase chain reaction (PCR) devices, which are used for DNA testing. Other instruments can include hematology analyzers for blood cell counts, biochemistry analyzers for measuring chemical substances in the blood, and imaging devices like X-rays or MRIs. These instruments are designed to be highly accurate and efficient, allowing for quick and reliable diagnoses.

Reagents are the chemical substances or compounds used in conjunction with diagnostic instruments to conduct tests. They interact with the samples of blood, urine, or tissue to produce measurable outcomes. Reagents can include antibodies used in immunoassays, chemical indicators, and enzymes. They are typically produced under strict quality control measures to ensure their efficacy and reliability.

Breakup by End User:

Hospital Laboratory

Diagnostic Laboratory

Point-of-care Testing

Others

Diagnostic laboratory dominates the market

The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospital laboratory, diagnostic laboratory, point-of-care testing, and others. According to the report, diagnostic laboratory represented the largest segment. Diagnostic laboratories are specialized facilities that focus solely on conducting diagnostic tests. They often serve multiple healthcare providers and may even accept samples from across different regions. These labs typically offer a wide array of tests, including specialized ones that a hospital lab might not provide. Diagnostic laboratories are crucial for outpatient care and ongoing monitoring of chronic conditions.

Point-of-care testing (POCT) refers to diagnostic tests that are conducted at or near the site where care is provided, usually by non-laboratory personnel. These tests are often simpler and quicker, designed to provide immediate results that can be acted upon without delay. Examples include glucose monitoring for diabetes patients and rapid strep tests in a primary care setting. POCT is invaluable in situations that require quick decision-making and immediate treatment.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest clinical diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The increasing awareness about the benefits of clinical diagnostics among the masses represents one of the primary factors bolstering the market growth in the North American region. Moreover, the rising adoption of automation in medical testing is contributing to the market growth in the region. Besides this, the growing utilization of mobile health (m-health) applications is influencing the market positively.

Competitive Landscape:

The leading companies are integrating artificial intelligence (AI), machine learning (ML), and the internet of things (IoT) to interpret complex data sets, including medical images like X-rays and MRIs that can identify patterns and anomalies that can be missed by human eyes, thereby increasing the accuracy of diagnoses. They are also using genomic sequencing technologies like next-generation sequencing (NGS) that enable rapid and accurate identification of genetic markers for various diseases, which allows for personalized treatment plans that are more targeted and effective. Moreover, key players are utilizing liquid biopsy that allows for the detection of cancer cells or DNA fragments in the blood, which offers a less invasive alternative to traditional tissue biopsies.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abbott Laboratories

Becton Dickinson and Company

bioMerieux SA

Bio-Rad Laboratories Inc.

Danaher Corporation

F. Hoffmann-La Roche AG

Qiagen N.V.

Quest Diagnostics Incorporated

Siemens AG

Sysmex Corporation

Thermo Fisher Scientific Inc

Recent Developments:

In 2022, Qiagen N.V. developed NeuMoDxHSV 1/2 Quant Assay for the quantification and differentiation of herpes simplex virus type 1 (HSV-1) DNA and/or herpes simplex virus type 2 (HSV-2) with approval from the European Commission.

In 2021, F. Hoffmann-La Roche AG acquired GenMark Diagnostics Inc. to access novel technology and test for pathogens with one patient sample.

In 2023, Abbott Laboratories recently signed a definitive agreement to acquire Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes.

Key Questions Answered in This Report

  • 1. What was the size of the global clinical diagnostics market in 2023?
  • 2. What is the expected growth rate of the global clinical diagnostics market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global clinical diagnostics market?
  • 4. What are the key factors driving the global clinical diagnostics market?
  • 5. What is the breakup of the global clinical diagnostics market based on the test?
  • 6. What is the breakup of the global clinical diagnostics market based on the product?
  • 7. What is the breakup of the global clinical diagnostics market based on the end user?
  • 8. What are the key regions in the global clinical diagnostics market?
  • 9. Who are the key players/companies in the global clinical diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Clinical Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test

  • 6.1 Lipid Panel
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Liver Panel
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Renal Panel
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Complete Blood Count
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Electrolyte Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Infectious Disease Testing
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Reagents
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital Laboratory
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratory
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Point-of-care Testing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Bio-Rad Laboratories Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Danaher Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Qiagen N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Quest Diagnostics Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sysmex Corporation
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Clinical Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Clinical Diagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Clinical Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Clinical Diagnostics Market: Breakup by Test (in %), 2023
  • Figure 5: Global: Clinical Diagnostics Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Clinical Diagnostics Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Clinical Diagnostics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Clinical Diagnostics (Lipid Panel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Clinical Diagnostics (Lipid Panel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Clinical Diagnostics (Liver Panel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Clinical Diagnostics (Liver Panel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Clinical Diagnostics (Renal Panel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Clinical Diagnostics (Renal Panel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Clinical Diagnostics (Complete Blood Count) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Clinical Diagnostics (Complete Blood Count) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Clinical Diagnostics (Electrolyte Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Clinical Diagnostics (Electrolyte Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Clinical Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Clinical Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Clinical Diagnostics (Other Tests) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Clinical Diagnostics (Other Tests) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Clinical Diagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Clinical Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Clinical Diagnostics (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Clinical Diagnostics (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Clinical Diagnostics (Other Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Clinical Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Clinical Diagnostics (Hospital Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Clinical Diagnostics (Hospital Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Clinical Diagnostics (Diagnostic Laboratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Clinical Diagnostics (Diagnostic Laboratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Clinical Diagnostics (Point-of-care Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Clinical Diagnostics (Point-of-care Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Clinical Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Clinical Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Clinical Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Clinical Diagnostics Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Clinical Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Clinical Diagnostics Industry: SWOT Analysis
  • Figure 86: Global: Clinical Diagnostics Industry: Value Chain Analysis
  • Figure 87: Global: Clinical Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Clinical Diagnostics Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Clinical Diagnostics Market Forecast: Breakup by Test (in Million US$), 2024-2032
  • Table 3: Global: Clinical Diagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Clinical Diagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Clinical Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Clinical Diagnostics Market: Competitive Structure
  • Table 7: Global: Clinical Diagnostics Market: Key Players